U.S. markets closed
  • S&P Futures

    3,832.50
    -1.50 (-0.04%)
     
  • Dow Futures

    30,914.00
    -22.00 (-0.07%)
     
  • Nasdaq Futures

    11,812.50
    +4.00 (+0.03%)
     
  • Russell 2000 Futures

    1,739.50
    -2.20 (-0.13%)
     
  • Crude Oil

    100.25
    +0.75 (+0.75%)
     
  • Gold

    1,768.10
    +4.20 (+0.24%)
     
  • Silver

    19.13
    +0.01 (+0.05%)
     
  • EUR/USD

    1.0265
    -0.0005 (-0.05%)
     
  • 10-Yr Bond

    2.8090
    -0.0800 (-2.77%)
     
  • Vix

    27.54
    +0.01 (+0.04%)
     
  • GBP/USD

    1.1961
    +0.0009 (+0.08%)
     
  • USD/JPY

    135.2840
    -0.5580 (-0.41%)
     
  • BTC-USD

    19,875.41
    -381.25 (-1.88%)
     
  • CMC Crypto 200

    429.99
    -10.03 (-2.28%)
     
  • FTSE 100

    7,025.47
    -207.18 (-2.86%)
     
  • Nikkei 225

    26,116.27
    -307.20 (-1.16%)
     

U.S. FDA gets complaint of one more infant death related to baby formula

·1 min read

June 22 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it was notified of one more infant death in January potentially related to Abbott Laboratories' baby formula and the agency has started a probe.

Abbott initiated a recall of its infant formula products https://www.reuters.com/business/healthcare-pharmaceuticals/what-happened-with-abbott-baby-formula-that-worsened-us-shortage-2022-05-16 and closed its Michigan plant in February after reports of serious bacterial infections in four infants, worsening a shortage among multiple manufacturers that began with pandemic supply chain issues. (Reporting by Amruta Khandekar; Editing by Shounak Dasgupta)